Drug Trial Radar · NCT06038630
129Xe MRI Cardiopulmonary
Last checked: Nov 20, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
125
Planned (sponsor's estimate)
Start
Jan 12, 2024
Primary completion
Jun 30, 2028
Study completion Jun 30, 2028
Sponsor
- Lead sponsor
- Bastiaan DriehuysAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institutes of Health (NIH)
- First posted
- Sep 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.
Conditions
- Interstitial Lung Disease
- Chronic Thromboembolic Pulmonary Hypertension
- Acute Pulmonary Embolism
- Anemia
- Polycythemia
- Dyspnea
Interventions
Hyperpolarized Xe129Drug
Hyperpolarized xenon will be administered in multiple doses in volumes up to 25% of subject TLC followed by a breath hold of up to 15 seconds.
Oxygen AdministrationOther
Oxygen administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in RBC to Membrane Ratio Pre and Post Transfusion or ApheresisTime frame: Up to 5 days pre/post transfusion or apheresis
- Change in RBC (red blood cell) Chemical Shift After Oxygen AdministrationTime frame: Baseline, 1 day
- Change in RBC Oscillation Amplitude Post TherapyTime frame: Baseline, 3-6 months post-treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Duke University Medical Center
Durham, North Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.